Literature DB >> 1867302

Treatment of pseudotumor cerebri by primary and secondary optic nerve sheath decompression.

T C Spoor1, J M Ramocki, M P Madion, M J Wilkinson.   

Abstract

We performed optic nerve sheath decompression in 53 patients (101 eyes) with pseudotumor cerebri and visual loss. Sixty-nine eyes (85 patients) with acute papilledema uniformly had improved visual function after optic nerve sheath decompression. Of 32 eyes with chronic papilledema (18 patients), only ten had improved visual function after optic nerve sheath decompression. This difference was significant (P = .0001). Thirteen eyes required secondary or tertiary optic nerve sheath decompression after an initial successful result. Eleven of 13 eyes had improved visual function after repeat optic nerve sheath decompression. We believe that patients with acute papilledema and visual loss should be offered optic nerve sheath decompression, and if symptoms recur, repeat optic nerve sheath decompression is a safe and effective treatment option.

Entities:  

Mesh:

Year:  1991        PMID: 1867302     DOI: 10.1016/s0002-9394(14)76698-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

1.  A 14-year-old Nigerian female with idiopathic intracranial hypertension (Pseudotumor cerebri or benign intracranial hypertension).

Authors:  A C Onwuchekwa; C N Nwankwo; E N Chapp-Jumbo
Journal:  Afr Health Sci       Date:  2002-12       Impact factor: 0.927

Review 2.  Diagnosis and management of benign intracranial hypertension.

Authors:  D Soler; T Cox; P Bullock; D M Calver; R O Robinson
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

3.  Effect of mitomycin C on the optic nerve in rabbits.

Authors:  H Mietz; T C Prager; C Schweitzer; J Patrinely; J R Valenzuela; R L Font
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

4.  Optic nerve sheath fenestration: a revised lateral approach for nerve access.

Authors:  Nathan W Blessing; David T Tse
Journal:  Orbit       Date:  2018-03-22

5.  Long-Term Results of Optic Nerve Sheath Fenestration for Idiopathic Intracranial Hypertension: Earlier Intervention Favours Improved Outcomes.

Authors:  Stacy L Pineles; Nicholas J Volpe
Journal:  Neuroophthalmology       Date:  2013-01-29

6.  Choroidal infarction in fulminant idiopathic intracranial hypertension.

Authors:  Cédric Lamirel; Beau B Bruce; Nancy Newman; Valérie Biousse
Journal:  J Neuroophthalmol       Date:  2010-06       Impact factor: 3.042

Review 7.  Papilledema: are we any nearer to a consensus on pathogenesis and treatment?

Authors:  Andrew G Lee; Michael Wall
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

8.  Meta-Analysis of CSF Diversion Procedures and Dural Venous Sinus Stenting in the Setting of Medically Refractory Idiopathic Intracranial Hypertension.

Authors:  S R Satti; L Leishangthem; M I Chaudry
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-06       Impact factor: 3.825

Review 9.  Papilledema: epidemiology, etiology, and clinical management.

Authors:  Mohammed Rigi; Sumayya J Almarzouqi; Michael L Morgan; Andrew G Lee
Journal:  Eye Brain       Date:  2015-08-17

10.  Optic nerve sheath decompression for visual loss in intracranial hypertension: report from a tertiary care center in South India.

Authors:  Suneetha Nithyanandam; George J Manayath; Ravindra R Battu
Journal:  Indian J Ophthalmol       Date:  2008 Mar-Apr       Impact factor: 1.848

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.